Development of Mycobacterium tuberculosis Enoyl Acyl Reductase (InhA) Inhibitors: A Mini-Review

被引:0
|
作者
Tailor, Navin Kumar [1 ]
Deswal, Geeta [2 ]
Guarve, Kumar [2 ]
Grewal, Ajmer Singh [2 ]
机构
[1] Univ Inst Pharm Sci, Chandigarh Univ, Mohali, Punjab, India
[2] Guru Gobind Singh Coll Pharm, Yamunanagar 135001, Haryana, India
关键词
Mycobacterium tuberculosis; antitubercular agents; enoyl acyl carrier protein reductase (InhA); InhA inhibitors; SARs; CARRIER PROTEIN REDUCTASE; FATTY-ACID BIOSYNTHESIS; SUBSTRATE-BINDING LOOP; ACP REDUCTASE; FURANYL-RHODANINES; CRYSTAL-STRUCTURE; DERIVATIVES; TARGETS; DESIGN; DRUGS;
D O I
10.2174/0113895575309785240902102421
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review article delves into the critical role of Enoyl acyl carrier protein Reductase (InhA; ENR), a vital enzyme in the NADH-dependent acyl carrier protein reductase family, emphasizing its significance in fatty acid synthesis and, more specifically, the biosynthesis of mycolic acid. The primary objective of this literature review is to elucidate diverse scaffolds and their developmental progression targeting InhA inhibition, thereby disrupting mycolic acid biosynthesis. Various scaffolds, including thiourea, piperazine, thiadiazole, triazole, quinazoline, benzamide, rhodanine, benzoxazole, and pyridine, have been systematically explored for their potential as InhA inhibitors. Noteworthy findings highlight thiadiazole and triazole derivatives, demonstrating promising IC50 values within the nanomolar concentration range. The review offers comprehensive insights into InhA's structure, structure-activity relationships, and a detailed overview of distinct scaffolds as effective inhibitors of InhA.
引用
收藏
页码:219 / 233
页数:15
相关论文
共 50 条
  • [21] Rational approach in the new antituberculosis agent design:: inhibitors of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis
    Andrade, Carolina Horta
    Mesquita Pasqualoto, Kerly Fernanda
    Zaim, Marcio Henrique
    Ferreira, Elizabeth Igne
    REVISTA BRASILEIRA DE CIENCIAS FARMACEUTICAS, 2008, 44 (02): : 167 - 179
  • [22] Structure-Based Design of a Novel Class of Potent Inhibitors of InhA, the Enoyl Acyl Carrier Protein Reductase from Mycobacterium Tuberculosis: A Computer Modelling Approach
    Rao, Gita Subba
    Vijayakrishnan, Rajakrishnan
    Kumar, Manoj
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (05) : 444 - 449
  • [23] Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis
    He, Xin
    Alian, Akram
    Stroud, Robert
    de Montellano, Paul R. Ortiz
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6308 - 6323
  • [24] MEDI 327-Pyrrolidine carboxamide as novel class inhibitor of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis (InhA)
    He, Xin
    Akram, Alian
    Stroud, Robert
    de Montellano, Paul R. Ortiz
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [25] Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis
    Tripathi, Ankit
    Wadia, Nupur
    Bindal, Deepak
    Jana, Tarakanta
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2012, 49 (06): : 435 - 441
  • [26] Using Virtual Screening to Identify Novel Inhibitors for Enoyl-Acyl Carrier Protein Reductase in Mycobacterium tuberculosis
    Mayberry, Sarah
    Beckham, Josh
    FASEB JOURNAL, 2021, 35
  • [27] Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis
    Sink, Roman
    Sosic, Izidor
    Zivec, Matej
    Fernandez-Menendez, Raquel
    Turk, Samo
    Pajk, Stane
    Alvarez-Gomez, Daniel
    Lopez-Roman, Eva Maria
    Gonzales-Cortez, Carolina
    Rullas-Triconado, Joaquin
    Angulo-Barturen, Inigo
    Barros, David
    Ballell-Pages, Lluis
    Young, Robert J.
    Encinas, Lourdes
    Gobec, Stanislav
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (02) : 613 - 624
  • [28] Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate
    Rozwarski, DA
    Vilchèze, C
    Sugantino, M
    Bittman, R
    Sacchettini, JC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) : 15582 - 15589
  • [29] Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence
    Dhivya, L. S.
    Sarvesh, Sabarathinam
    Singh, Ankul S.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (12): : 5399 - 5417
  • [30] Design, synthesis and computational approach to study novel pyrrole scaffolds as active inhibitors of enoyl ACP reductase (InhA) and Mycobacterium tuberculosis antagonists
    Kumar, S. R. Prem
    Shaikh, Ibrahim Ahmed
    Mahnashi, Mater H.
    Alshahrani, Mohammed Abdulrahman
    Dixit, Sheshagiri R.
    Kulkarni, Venkatarao H.
    Lherbet, Christian
    Gadad, Andanappa K.
    Aminabhavi, Tejraj M.
    Joshi, Shrinivas D.
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2022, 99 (11)